The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
MECHANISMS IN ENDOCRINOLOGY: Heart failure and thyroid dysfunction
Abstract
Context: Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the United States. The aim of this review article was to assess the results of the prospective studies that evaluated the risk of HF in patients with overt and subclinical thyroid disease and discuss the mechanism of this dysfunction. Evidence Acquisition: Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation. The investigation was restricted to reports published in English. Evidence Synthesis: The outcome of this analysis suggests that patients with untreated overt thyroid dysfunction are at increased risk of HF. Moreover, persistent subclinical thyroid dysfunction is associated with the development of HF in patients with serum TSH <0.1 or >10 mU/l. Conclusions: The timely recognition and effective treatment of cardiac symptoms in patients with thyroid dysfunction is mandatory because the prognosis of HF may be improved with the appropriate treatment of thyroid dysfunction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stroke is a potential complication of AF in overt hyperthyroidism [68] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [68]
In the citing paper
“These alterations may be reversible or improve when euthyroidism is restored because thyroid hormone excess does not induce cardiac fibrosis [68] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [68]
In the citing paper
“The onset of AF may increase CV morbidity and mortality, resulting from severe HF and stroke (75).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [75]
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,739
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Trends in Heart Failure Incidence and Survival in a Community-Based Population
Roger, V. L. (2004) · JAMA · doi:10.1001/jama.292.3.344 · Cited by 1,616
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
Jessup, M. L., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., MANCINI, D. M., Rahko, P. S., Silver, M. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192064 · Cited by 1,425
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Self-citationHunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,398
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Predicting Mortality Among Patients Hospitalized for Heart Failure
Lee, D. S., Austin, P. C., Rouleau, J. L., Liu, P. P., Naimark, D. M. J., & Tu, J. V. (2003) · JAMA · doi:10.1001/jama.290.19.2581 · Cited by 1,270
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Self-citationThyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
Bergh, J. J., Lin, H., Lansing, L., Mohamed, S. N., Davis, F. B., Mousa, S. A., & Davis, P. J. (2005) · Endocrinology · doi:10.1210/en.2005-0102 · Cited by 563
Gencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503
Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease
Iervasi, G., Pingitore, A., Landi, P., Raciti, M., Ripoli, A., Scarlattini, M., L’Abbate, A., & Donato, L. (2003) · Circulation · doi:10.1161/01.cir.0000048124.64204.3f · Cited by 472
Effects of Thyroid Hormone on the Cardiovascular System
Fazio, S. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.31 · Cited by 445
Hypothyroidism as a Risk Factor for Cardiovascular Disease
Biondi, B., & Klein, I. L. (2004) · Endocrine · doi:10.1385/endo:24:1:001 · Cited by 411
Self-citationMechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions
Bassett, J. H. D., Harvey, C. B., & Williams, G. R. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.033 · Cited by 392
Razvi, S., Ingoe, L., Keeka, G., Oates, C., McMillan, C., & Weaver, J. U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1869 · Cited by 389
Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, C. E., Ertl, G., & Lohse, M. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20149 · Cited by 384
Mechanisms of nongenomic actions of thyroid hormone
Davis, P. J., Leonard, J. L., & Davis, F. B. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.09.003 · Cited by 364
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
Luiza Maia, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25083 · Cited by 360
Biondi, B. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4701 · Cited by 356
Self-citationRazvi, S., Shakoor, A., Vanderpump, M., Weaver, J. U., & Pearce, S. H. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0167 · Cited by 330
Association between increased mortality and mild thyroid dysfunction in cardiac patients
Iervasi, G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1526 · Cited by 285
Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure
Rodondi, N., Bauer, D. C., Cappola, A. R., Cornuz, J., Robbins, J., Fried, L. P., Ladenson, P. W., Vittinghoff, E., Gottdiener, J. S., & Newman, A. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.009 · Cited by 273
Razvi, S., Weaver, J. U., Butler, T. J., & Pearce, S. H. S. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.1159 · Cited by 266
Thyroid Replacement Therapy and Heart Failure
Gerdes, A. M., & Iervasi, G. (2010) · Circulation · doi:10.1161/circulationaha.109.917922 · Cited by 249
Siu, C., Yeung, C. Y., Lau, C. P., Kung, A. W. C., & Tse, H.-F. (2006) · Heart · doi:10.1136/hrt.2006.100628 · Cited by 246
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8302 · Cited by 245
Self-citationSomwaru, L. L., Arnold, A. M., Joshi, N., Fried, L. P., & Cappola, A. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1696 · Cited by 239
Thyroid Diseases and Cerebrovascular Disease
Squizzato, A., Gerdes, V. E. A., Brandjes, D. P. M., Büller, H. R., & Stam, J. (2005) · Stroke · doi:10.1161/01.str.0000181772.78492.07 · Cited by 236
Cardiovascular involvement in patients with different causes of hyperthyroidism
Biondi, B., & Kahaly, G. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.105 · Cited by 230
Self-citationRohrer, D. K., & DILLMANN, W. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68584-9 · Cited by 228
Abnormal Left Ventricular Function in Hyperthyroidism
Forfar, J. C., Muir, A. L., Sawers, S., & Toft, A. D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211043071901 · Cited by 226
Subclinical hyperthyroidism: clinical features and treatment options
Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., & Lombardi, G. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01809 · Cited by 217
Self-citationNanchen, D., Gussekloo, J., Westendorp, R. G. J., Stott, D. J., Jukema, J. W., Trompet, S., Ford, I., Welsh, P., Sattar, N., Macfarlane, P. W., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1978 · Cited by 211
Triiodothyronine levels for risk stratification of patients with chronic heart failure
Pingitore, A., Landi, P., Taddei, M. C., Ripoli, A., L’Abbate, A., & Iervasi, G. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.07.052 · Cited by 192
Cruz, F. E. S., Cheriex, E. C., Smeets, J. L. R. M., Atié, J., Péres, A. K., Penn, O. C. K. M., Brugada, P., & Wellens, H. J. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90368-y · Cited by 188
Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans
Napoli, R., Biondi, B., Guardasole, V., Matarazzo, M., Pardo, F., Angelini, V., Fazio, S., & Saccà, L. (2001) · Circulation · doi:10.1161/hc5001.100621 · Cited by 187
Self-citationTang, Y.-D., Kuzman, J. A., Said, S., Anderson, B. E., Wang, X., & Gerdes, A. M. (2005) · Circulation · doi:10.1161/circulationaha.105.572883 · Cited by 179
Ladenson, P. W., Sherman, S. I., Baughman, K. L., Ray, P. E., & Feldman, A. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5251 · Cited by 175
A critical review and meta-analysis of the association between overt hyperthyroidism and mortality
Brandt, F., Green, A., Hegedüs, L., & Brix, T. H. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0299 · Cited by 170
Does subclinical hypothyroidism affect cardiac pump performance?
Ripoli, A., Pingitore, A., Favilli, B., Bottoni, A., Turchi, S., Osman, N. F., De Marchi, D., Lombardi, M., L'Abbate, A., & Iervasi, G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.044 · Cited by 157
Eskes, S. A., & Wiersinga, W. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.001 · Cited by 148
The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence
Galli, E., Pingitore, A., & Iervasi, G. (2010) · Heart Failure Reviews · doi:10.1007/s10741-008-9126-6 · Cited by 132
Thyroid hormone and angiogenesis
Luidens, M. K., Mousa, S. A., Davis, F. B., Lin, H., & Davis, P. J. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.10.007 · Cited by 127
Subclinical Hypothyroidism and Cardiac Function
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · Thyroid · doi:10.1089/105072502760143890 · Cited by 125
Self-citationSiu, C.-W., Zhang, X.-H., Yung, C., Kung, A. W. C., Lau, C.-P., & Tse, H.-F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1877 · Cited by 121
Signaling Pathways Responsible for Fetal Gene Induction in the Failing Human Heart
Kinugawa, K., Minobe, W. A., Wood, W. M., Ridgway, E. C., Baxter, J. D., Ribeiro, R. C. J., Tawadrous, M., Lowes, B. D., Long, C. S., & Bristow, M. R. (2001) · Circulation · doi:10.1161/01.cir.103.8.1089 · Cited by 121
Brenta, G., Mutti, L. A., Schnitman, M., Fretes, O., Perrone, A., & Matute, M. L. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00322-9 · Cited by 118
Goldman, S., McCarren, M., Morkin, E., Ladenson, P. W., Edson, R., Warren, S., Ohm, J., Thai, H., Churby, L., Barnhill, J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.834424 · Cited by 117
Thyroid Hormone Therapy for Obesity and Nonthyroidal Illnesses: A Systematic Review
Kaptein, E. M., Beale, E., & Chan, L. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0899 · Cited by 110
Cardiovascular Effects of Mild Hypothyroidism
Biondi, B. (2007) · Thyroid · doi:10.1089/thy.2007.0158 · Cited by 106
Self-citationHyperthyroidism as a high cardiac output state
deGroot, W. J., & Leonard, J. J. (1970) · American Heart Journal · doi:10.1016/0002-8703(70)90318-2 · Cited by 105
Pulmonary Hypertension and Thyroid Disease
Li, J. H., Safford, R. E., Aduen, J. F., Heckman, M. G., Crook, J. E., & Burger, C. D. (2007) · CHEST Journal · doi:10.1378/chest.07-0366 · Cited by 103
Thyroid Disease and Vascular Function
Owen, P. J. D., Sabit, R., & Lazarus, J. H. (2007) · Thyroid · doi:10.1089/thy.2007.0051 · Cited by 101
Natural history, diagnosis and management of subclinical thyroid dysfunction
Biondi, B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.004 · Cited by 98
Self-citationHenderson, K. K., Danzi, S. E., Paul, J. T., Leya, G. A., Klein, I. L., & Samarel, A. M. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.810747 · Cited by 97
Amiodarone-Induced Thyrotoxicosis Is a Predictor of Adverse Cardiovascular Outcome
Yiu, K., Jim, M., Siu, C., Lee, C., Yuen, M. M. A., Mok, M. M. Y., Shea, Y.-F., Fan, K., Tse, H., & Chow, W. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1907 · Cited by 96
Evidence for the Presence of Functional Thyrotropin Receptor in Cardiac Muscle
Drvota, V., Janson, A., Norman, C., Sylvén, C., Häggblad, J., Brönnegård, M., & Marcus, C. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1831 · Cited by 94
Downregulation of Vascular Angiotensin II Type 1 Receptor by Thyroid Hormone
Fukuyama, K., Ichiki, T., Takeda, K., Tokunou, T., Iino, N., Masuda, S., Ishibashi, M., Egashira, K., Shimokawa, H., Hirano, K., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000056524.35294.80 · Cited by 84
Hyperthyroidism and pulmonary hypertension
Marvisi, M., Brianti, M., Marani, G., Borrello, P. D., Bortesi, M., & GUARIGLIA, A. (2002) · Respiratory Medicine · doi:10.1053/rmed.2001.1260 · Cited by 83
Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients
Iacoviello, M., Guida, P., Guastamacchia, E., Triggiani, V., Forleo, C., Catanzaro, R., Cicala, M., Basile, M., Sorrentino, S., & Favale, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786264142 · Cited by 82
Pachucki, J., Burmeister, L. A., & Larsen, P. R. (1999) · Circulation Research · doi:10.1161/01.res.85.6.498 · Cited by 81
Tomisti, L., Materazzi, G., Bartalena, L., Rossi, G., Marchello, A., Moretti, M., De Napoli, L., Mariotti, R., Miccoli, P., Martino, E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1797 · Cited by 75
Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy
Ojamaa, K. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.11.008 · Cited by 74
Lozano, H. F., & Sharma, C. N. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000137259.83169.e3 · Cited by 73
Increased risk of pulmonary embolism among patients with hyperthyroidism: a 5‐year follow‐up study
LIN, H. ‐., Yang, L.-Y., & Kang, J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03993.x · Cited by 67
Coordinated capillary and myocardial growth in response to thyroxine treatment
Tomanek, R. J., & Busch, T. L. (1998) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199805)251:1 · Cited by 66
Liu, Y., Xia, X., Fondell, J. D., & Yen, P. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0101 · Cited by 66
Khalife, W. I., Tang, Y.-D., Kuzman, J. A., Thomas, T. A., Anderson, B. E., Said, S., Tille, P. M., Schlenker, E. H., & Gerdes, A. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00483.2005 · Cited by 66
Liu, Z. (1990) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(90)90979-c · Cited by 63
Liu, Y., Redetzke, R. A., Said, S., Pottala, J. V., de Escobar, G. M., & Gerdes, A. M. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01379.2007 · Cited by 58
Cardiomyopathy associated with Graves' disease
Koshiyama, H., Sellittl, D. F., Akamizu, T., Doi, S. Q., Takeuchi, Y., Lnoue, D., Sakaguchl, H., Takemura, G., Sato, Y., Takatsun, Y., et al. (1996) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1996.tb02068.x · Cited by 57
Palmieri, E. A., Fazio, S., Palmieri, V., Lombardi, G., & Biondi, B. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500757 · Cited by 57
Self-citationThyroid Hormone Abnormalities in Heart Failure: Possibilities for Therapy
Hamilton, M. A., & Stevenson, L. W. (1996) · Thyroid · doi:10.1089/thy.1996.6.527 · Cited by 55
Yue, W., Chong, B.-H., Zhang, X.-H., Liao, S.-Y., Jim, M., Kung, A. W. C., Tse, H., & Siu, C. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03981.x · Cited by 54
Hyperthyroidism as a Cause of Pulmonary Arterial Hypertension: A Prospective Study
Armigliato, M., Paolini, R., Aggio, S., Zamboni, S., Galasso, M. P., Zonzin, P., & Cella, G. (2006) · Angiology · doi:10.1177/0003319706293131 · Cited by 53
Makino, A., Suárez, J., Wang, H., Belke, D. D., Scott, B. T., & DILLMANN, W. H. (2008) · Endocrinology · doi:10.1210/en.2008-0634 · Cited by 51
Boccalandro, C., Boccalandro, F., Orlander, P. R., & Wei, C. F. (2003) · Endocrine Practice · doi:10.4158/ep.9.2.140 · Cited by 49
Hospitalizations in Patients With Heart Failure: Who and Why
Setoguchi, S., & Stevenson, L. W. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.015 · Cited by 49
Thyroid Hormone Promotes Remodeling of Coronary Resistance Vessels
Savinova, O. V., Liu, Y., Aasen, G. A., Mao, K., Weltman, N. Y., Nedich, B. L., Liang, Q., & Gerdes, A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025054 · Cited by 48
Endothelial-mediated coronary flow reserve in patients with mild thyroid hormone deficiency
Biondi, B., Galderisi, M., Pagano, L., Sidiropulos, M., Pulcrano, M., Errico, A. D., Ippolito, S., Rossi, A., DIVITIIS, O. D., & Lombardi, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0196 · Cited by 48
Self-citationSilva-Tinoco, R., Castillo‐Martínez, L., Orea‐Tejeda, A., Orozco-Gutíerrez, J. J., Vázquez-Díaz, O., Montaño-Hernández, P., Flores-Rebollar, A., & Reza‐Albarrán, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.01.012 · Cited by 46
Thyroid Hormone and Cardiac Disease: From Basic Concepts to Clinical Application
Mourouzis, I. S., Forini, F., Pantos, C. I., & Iervasi, G. (2011) · Journal of Thyroid Research · doi:10.4061/2011/958626 · Cited by 44
Ismail, H. M. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0032-0 · Cited by 42
Ngo, A. S.-Y., & Tan, D. C. L. (2006) · Resuscitation · doi:10.1016/j.resuscitation.2006.01.009 · Cited by 36
Reversible dilated cardiomyopathy caused by hypothyroidism
Khochtali, I., Hamza, N., Harzallah, O., Hamdi, S., Saad, J., Golli, M., & Mahjoub, S. (2011) · International Archives of Medicine · doi:10.1186/1755-7682-4-20 · Cited by 34
Biondi, B. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0585 · Cited by 32
Self-citationThyrotoxicosis and pulmonary hypertension
Ronald, C. W., Cheng, A. Y., So, W. Y., Hui, D. S. C., Tong, P. C. Y., & Chow, C. C. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.038 · Cited by 24
Anjos-Ramos, L., Carneiro‐Ramos, M. S., Diniz, G. P., Martins-Silva, J., & Barreto‐Chaves, M. L. M. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-0140-y · Cited by 23
Regulation of arteriolar density in adult myocardium during low thyroid conditions
Liu, Y., Sherer, B. A., Redetzke, R. A., & Gerdes, A. M. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.10.003 · Cited by 22
Right heart failure and hyperthyroidism: a neglected presentation
Cohen, J., & Schattner, A. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00288-2 · Cited by 20
Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study
Frost, L., Vestergaard, P., & Mosekilde, L. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.013 · Cited by 17
Congestive heart failure in subjects with thyrotoxicosis in a black community
Anakwue, R. C. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s9871 · Cited by 15
Fatal thyrotoxic cardiomyopathy in a young man
Soh, M. C., & CROXSON, M. S. (2008) · BMJ · doi:10.1136/bmj.a531 · Cited by 13
Thyrotoxicosis-induced Congestive Heart Failure in an Urban Hospital
Wilson, B. E., & Newmark, S. R. (1994) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199412000-00006 · Cited by 12
Severe reversible right heart failure in a patient with hyperthyroidism
Syriou, V., Plastiras, S. C., Paterakis, T., Moyssakis, I. E., & Vlachoyiannopoulos, P. G. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00979.x · Cited by 9
Reversible Severe Tricuspid Regurgitation with Right Heart Failure Associated with Thyrotoxicosis
Park, J., Shong, M., Lee, J., Choi, S. W., Jeong, J., & Seong, I. W. (2006) · Thyroid · doi:10.1089/thy.2006.16.813 · Cited by 9
Fukuda, S., Hozumi, T., Muro, T., Watanabe, H., Hyodo, E., Yoshiyama, M., Takeuchi, K., & Yoshikawa, J. (2004) · Journal of Echocardiography · doi:10.2303/jecho.2.1 · Cited by 6
Clinical manifestations in forty cases of myxedema.
Schwimmer, D. B., Vogel, M., & MCGAVACK, T. H. (1947) · PubMed · Cited by 3
Hyperthyroidism and Risk of Atrial Fibrillation or Flutter: A Population-Based Study
Frost, L., Vestergaard, P., & Mosekilde, L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1675
Research works printed but not linked: 15
- 2009, Journal of the American College of Cardiology, 54, 173
- Biondi, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 968, 10.1210/jc.87.3.968 · DOI · Paper page
- 2000, Journal of Clinical Endocrinology & Metabolism, 85, 4702
- 2006, 70, 287
- 2008, BMJ, 28, 337
- 2001, NIGERIAN JOURNAL OF MEDICINE, 6, 50
- 2004, TROPICAL CARDIOLOGY, 118, 24
- 2010, VASCULAR HEALTH AND RISK MANAGEMENT, 6, 473
- Jahns, 2004, Journal of Clinical Investigation, 113, 1419, 10.1172/JCI200420149 · DOI
- 2007, Journal of Clinical Endocrinology & Metabolism, 2, 1736
- 2009, BEST PRACTICE AND RESEARCH CLINICAL ENDOCRINOLOGY AND METABOLISM, 6, 735
- McCLENDON, 1947, Journal of Clinical Endocrinology & Metabolism, 7, 468
- 2011, INTERNATIONAL ARCHIVES OF MEDICINE, 21, 4
- 2011, JOURNAL OF THYROID RESEARCH, 2011, 958626
- 2009, Circulation: Heart Failure, 3, 243
Cited by
Sorted by citations
2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729
Thyroid Hormones and Cardiovascular Function and Diseases
Razvi, S., Jabbar, A., Pingitore, A., Danzi, S., Biondi, B., Klein, I., Peeters, R., Zaman, A., & Iervasi, G. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.045 · Cited by 515
Self-citationBiondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Self-citationUdovcic, M., Pena, R. H., Patham, B., Tabatabai, L. S., & Kansara, A. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-2-55 · Cited by 308
Metadata
- Authors
- Biondi, B.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Biondi, Bernadette
- ORCID
- Biondi, Bernadette
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11
- Volume
- 167
- Issue
- 5
- Pages
- 609-618
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2071292391
- Cited by
- 291
- References
- 105
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 13 · 2023: 17 · 2022: 19 · 2021: 26 · 2020: 24 · 2019: 26 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 23 · 2014: 21 · 2013: 17 · 2012: 3
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure, thyroid dysfunction, subclinical hypothyroidism, subclinical hyperthyroidism, overt hypothyroidism, overt hyperthyroidism, thyroid hormone replacement, levothyroxine, triiodothyronine, antithyroid drugs, radioactive iodine, deiodinases, systolic function, diastolic function, endothelial function, amiodarone, atrial fibrillation, heart rate, systemic vascular resistance
- MeSH terms
- Amiodarone, Animals, Anti-Arrhythmia Agents, Atrial Fibrillation, Atrial Flutter, Coronary Disease, Heart Failure, Heart Rate, Humans, Hyperthyroidism, Hypothyroidism, Prognosis, Stroke Volume, Thyroid Diseases, Thyroid Hormones, Thyrotropin, Thyroxine, Triiodothyronine, Practice Guidelines as Topic, Disease Progression, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review